Phenol has been used widely in the last two decades for the inactivation of rabies virus since Semple (1911) described a successful procedure for the production of rabies vaccine using a concentration of phenol of 0.5 per cent and of 1 per cent. This concentration of phenol in the final product caused some tissue damage at the site of inoculation and lowered the potency and stability of the vaccine. In an effort to improve the quality of the vaccine the National Institutes of Health recommend that the final concentration of phenol be reduced to a maximum of 0.25 per cent.
The development of a procedure by Levinson et al. (1945) Jamieson and Powell (1931) and Morgan, Jamieson and Powell (1933) observed that bacterial antigens, toxins and toxoids preserved with Merthiolate gave rise to antibody titers in guinea pigs which were higher than those stimulated by the corresponding products which were killed by heat or preserved with phenol.
This observation, together with the knowledge that Merthiolate has an affinity for certain protein groups, led us to postulate that Merthiolate might inhibit certain enzymes or protect certain antigenic groups of rabies virus from the destructive action of phenol. Therefore, the effect of Merthiolate added to freshly prepared tissue emulsions immediately following the addition of phenol was studied.
It is the purpose of this report to present a method for the inactivation of rabies virus with phenol in the presence of Merthiolate, and to compare the antigenicity of the resulting vaccines with those prepared by (1) Inactivation by phenol alone (2) Inactivation by irradiation with ultraviolet light.
MATERIALS AND METHODS
Normal adult rabbits were injected intracerebrally with 0.2 ml of a 1 X 10-dilution of fixed rabies virus. After rabbits had shown symptoms of rabies for 24 hours or more, they were sacrificed by use of air embolism. The brain tissue was removed aseptically, a sample taken for sterility test, and, after weighing, the remainder was stored at minus (-) 50 C. A 50 per cent W/V tissue emulsion in sodium chloride solution 0.85 per cent was prepared by grinding in a colloid mill. A sample of the emulsion was removed for the determination of the virus titer. Sufficient phenol 4 per cent in sodium chloride solution 0.85 per cent was added to give a final phenol concentration of 0.8 per cent, and a tissue concentration of 40 per cent. The resulting emulsion was divided into aliquots of 500 to 600 ml each.
Merthiolate solution, 1 per cent, was added to one aliquot to give a final concentration of 1:10,000. No Merthiolate was added to the second aliquot. The emulsions were stored at room temperature, 20 to 25 C, for from 17 to 20 days for virus inactivation, and were then diluted with sodium chloride solution 0.85 per cent to a tissue concentration of 6.66 per cent. Merthiolate 1 per cent was added to each aliquot to give a final concentration of 1: 10,000 in the diluted emulsion.
The 6.66 per cent emulsion was tested in mice for viable virus. If viable virus was still present, the emulsion was re-incubated at room temperature for 5 to 10 days and then retested. Upon completion of a satisfactory test for virus viability in mice, a viability test was performed in rabbits. The potency (protective value) of the emulsion was then determined in accordance with the Minimum Requirements for Rabies Vaccine of the National Institutes of Health (1946) .
Inactivation by irradiation with ultraviolet light was performed as follows: An aliquot of the 50 per cent tissue emulsion described above was diluted to a 10 per cent W/V emulsion with sodium chloride solution 0.85 per cent. No phenol was added. The resulting emulsion was irradiated using the Dill Irradiator'. Uniform wetting of the rotating cylinder was accomplished by the use of a wetting agent, Aerosol O.T.2, at a dilution of 1: 500,000 V/V. The wetting agent was collected into a waste bottle through a Y-tube and discarded. Irradiation was performed using two "Slimline"s lamps at an angle of 45 degrees, speed of rotation 400 rpm, and at a flow rate of 206 to 388 ml/min. Merthiolate was added to a final concentration of 1:10,000 after irradiation.
The statistical analysis was made by determining the difference between the mean LD,o's of the two vaccines to determine whether the difference was significant or merely occurred because of sampling variation. A 
DISCUSSION
The addition of Merthiolate to a phenolized brain tissue emulsion may protect certain antigenic groups from the adverse effects of phenol. The mechanism for such action cannot be postulated without further study. It is significant that rabies vaccines of high antigenic value can be produced by the above procedure, and that in this laboratory this type of vaccine is comparable to experimental lots of vaccine which we have prepared using ultraviolet light as the inactivating agent.
The greatest importance of the procedure described above probably lies in terms of the simplicity of equipment and the amount of labor required to produce high potency rabies vaccine. It is also of importance that no serious reactions have been reported from doses of vaccine prepared by this procedure over the fouryear period in which approximately 27,000 doses of rabies vaccine were used annually in the State of Michigan. Although Negri bodies are demonstrated in an average of 300 animal heads each year, no cases of rabies im man have been reported during the four-year period in which this vaccine has been available.
